|
|||||||||
|
|
|
|
|
|
|
|
|
|
|
Prepublished online as a Blood First Edition Paper on December 27, 2002; DOI 10.1182/blood-2002-05-1341.
HEMATOPOIESIS
From INSERM U506, Hôpital Paul Brousse,
Villejuif, France; Laboratoire de Microscopie Electronique du service
d'Anatomopathologie, Hôpital Paul Brousse, Villejuif,
France; and Laboratoire
d'Hématopoïèse, Faculté de Médecine,
Tours, France.
Liver becomes the predominant site of hematopoiesis by 11.5 dpc
(days after coitus) in the mouse and 15 gestational weeks in
humans and stays so until the end of gestation. The reason the liver is
the major hematopoietic site during fetal life is not clear. In this
work, we tried to define which of the fetal liver microenvironmental
cell populations would be associated with the development of
hematopoiesis and found that a population of cells with mixed
endodermal and mesodermal features corresponded to
hematopoietic-supportive fetal liver stroma. Stromal cells generated
from primary cultures or stromal lines from mouse or human fetal liver
in the hematopoietic florid phase expressed both mesenchymal markers
(vimentin, osteopontin, collagen I, In adult mammals, hematopoietic stem cells (HSCs)
reside in the bone marrow. During ontogenesis HSCs are detected at
other sites.1 In the embryo a transitional primitive
population of HSCs is found in the yolk sac, while HSCs responsible for
definitive hematopoiesis are found in the embryo proper, within the
aorta-gonad-mesonephros (AGM) region. HSCs then migrate to the fetal
liver, which remains the major site of hematopoiesis until the end of
gestation. Bone marrow takes over after birth.
Hematopoiesis in the liver is first detected by 10.5 dpc (days
after coitus) in the mouse and by 5 gestational weeks (gw) in humans.
The liver becomes the predominant hematopoietic site by 11.5 dpc and 15 gw and stays so until the end of gestation. HSCs in the fetal liver
present functional and phenotypic properties distinctive from those of
adult bone marrow. They are highly proliferative, and between 13 and 15 dpc there is considerable increase in HSCs numbers.2 Fetal
liver HSCs, compared with marrow HSCs, express the membrane
glycoproteins AA4.1 and Mac-1.2,3 Fetal liver hematopoietic progenitor cells appear to follow the same
differentiation hierarchy as marrow progenitors.4 However,
fetal liver progenitors are less strictly lineage
restricted,4 and erythroid progenitors are more readily
obtained from precursors5 and show a specific pattern of
response to cytokines.6 Remarkably, progenitors from fetal
liver show a proliferative capacity in culture superior to that of
progenitors obtained later in development, from the cord blood or from
the bone marrow.7
In the mouse, liver development begins by 8.5 dpc.8
Although it has been proposed that the liver parenchyma may derive from
the septum transversum mesenchyme, lineage tracing studies and tissue
explant coculture experiments strongly support that hepatocytes descend
directly from the endoderm.8,9 The precardiac and the
septum transversum mesenchymes are necessary for hepatic specification,
inducing the ventral foregut endoderm to proliferate and subsequently
adopt a hepatic fate, forming the liver bud.8,10 A number
of cytokines are critical for hepatic differentiation and maturation.
Liver is induced in the endoderm by convergent fibroblast growth factor
(FGF) and bone morphogenetic protein (BMP) signaling from cardiac
mesoderm and septum transversum mesenchyme.11 Hepatic
differentiation from embryonic stem cells also involves FGF at an early
stage of culture, while hepatocyte growth factor (HGF), oncostatin M
(OSM), glucocorticoids, and insulin are involved in subsequent
maturation.12
Cells resulting from the early hepatic differentiation of endoderm
(hepatoblasts) are bipotent cells able to give rise to mature
hepatocytes and bile duct epithelial cells, both of which morphologically differentiate during the second half of fetal development and during the first few postnatal days in the
mouse.13 Hepatoblasts, contrary to hepatocytes, are round,
nonpolarized cells and express weakly, or not at all, some membrane
antigens expressed by hepatocytes.14 In addition,
hepatoblasts express In many respects, hepatoblasts appear similar to oval cells
proliferating in response to liver damage.17 Oval cells
are thought to be related to liver stem cells.13 Liver
stem cells express HSC markers such as Thy-1 and
c-kit18,19 and would produce not only hepatocytes and bile
epithelial cells belonging to the adult liver but also generate
pancreas and even intestine.20-22 However, larger
differentiation potential may be the consequence of stem cell
plasticity, unrelated to hepatic stem cells as such. Recent data
indicate that HSCs may give rise to hepatocytes.23,24 Reconstitution of the liver would therefore result from 3 cell types,
depending on the nature and the anatomic site of the injury: hepatocytes,25 intrahepatic periportal/periductular stem
cells/progenitors (oval cells), and extrahepatic stem
cells.26-30 The reason the liver is the major
hematopoietic site during fetal life is not clear. That the bone marrow
is not yet mature at this period and that fetal HSCs present specific
characteristics do not explain the specific HSC homing to the
fetal liver tissue. In this work we tried to define which of the
microenvironmental cell populations within the fetal liver would be
associated with the development of hematopoiesis and found that a
population of cells with mixed endodermal (epithelial) and mesodermal
features corresponds to the hematopoietic-supportive fetal liver
stroma. Such a cell population fits with the description of cells in
epithelial-to-mesenchymal transition (EMT), often observed during
development,31,32 including that of
liver.33,34 This population disappears by the end of gestation, being replaced by hepatocytes.
Cell cultures
C57BL/6 mice were mated overnight, and noon of the day of the vaginal
plug was defined as 0.5 dpc. At specified times (11.5, 12.5, 14.5, and
18 dpc), mice were killed by cervical dislocation, and the uteri were
removed from the peritoneum and washed with several changes of Iscove
modified Dulbecco medium (IMDM). Livers were removed from embryos by microdissection.
Human or murine fetal liver cells were dispersed in Hanks balanced salt
solution containing 5% (vol/vol) fetal calf serum (FCS) by flushing
through needles of graded sizes. Single-cell suspensions were obtained
by treatment with 250 IU collagenase type I (Sigma, St Louis, MO) for
30 minutes at 37°C and vigorous pipetting. Trypan blue-negative
cells (2 × 106/mL) were then cultured in flasks or onto
8-chamber Permanox slides in the long-term culture medium consisting of
50% (vol/vol) Myelocult (StemCell Technologies, Vancouver, BC,
Canada), 35% (vol/vol) Fetal liver stromal cell lines used in this study (AFT024, 2018, and
BFC012) were established by culturing stromal cell clones from 14-dpc
fetal liver35 and were provided by Kateri Moore (Princeton
University, NJ). Cells were cultured in Dulbecco modified Eagle medium
(DMEM) supplemented with 20% FCS and 50 µM Antibodies
Morphologic analyses of stromal cells Immunofluorescence. Cells from human or murine fetal liver or cells from the stromal lines were seeded onto chamber slides (5000 to 10 000 cells per chamber). Adherent layers were examined at optimal confluency (after 5 to 10 days). For detection of cytoskeletal elements, cells were permeabilized and fixed with methanol. For cell surface molecule detection, cells were fixed with 4% (vol/vol) paraformaldehyde and 0.1% (vol/vol) glutaraldehyde. All incubations were performed at 4°C for 30 minutes. Flow cytometry. For analysis of membrane antigens, stromal cells grown in flasks were treated with trypsin. Cells in suspension were then stained sequentially with primary antibodies and fluorescein-conjugated secondary antibodies. Cells were also stained with 4 µg/mL propidium iodide in phosphate-buffered saline (PBS) before being passed through a FACSCalibur (Becton Dickinson, Mountain View, CA) flow cytometer. For each analysis, 5000 events were recorded. Appropriate gating was performed using the forward scatter (FSC) versus side scatter (SSC) dot plot and gating out propidium iodide-positive dead cells. The histogram for each antibody was compared with that of the relevant control. For intracellular antigens, cells were first permeabilized with orthopermeaFIX (Ortho Diagnostic System) at room temperature for 45 minutes. Western blotting. Adherent layers from stromal lines, grown in flasks, were detached with cold phosphate-buffered saline (PBS) containing 10 mM EDTA (ethylenediaminetetraacetic acid) and then lysed by sonication in a buffer containing PBS, 10 mM EDTA, and 10 µg/mL protease inhibitors (Boehringer Mannheim, Germany). An aliquot of each lysate was removed for protein concentration using the BCA assay (Pierce, Rockville, IL). For sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), samples were resuspended in Laemmli buffer (10% [vol/vol] glycerol, 100 mM dithiothreitol [DTT], 2% [wt/vol] SDS, 50 mM Tris (tris(hydroxymethyl)aminomethane)-HCl [pH 6.8], and 0.002% [wt/vol] bromophenol blue), boiled for 5 minutes, and separated on a 10% (wt/vol) polyacrylamide gel. Each lane contained 50 µg proteins. Prestained molecular weight standards were run in parallel. After electrophoresis, proteins were transferred onto nitrocellulose membrane in buffer containing 25 mM Tris-HCl, 192 mM glycine, 20% (vol/vol) methanol, and 0.01% SDS. Nonspecific protein binding sites were blocked by incubation for 2 hours at room temperature in TBST buffer (20 mM Tris-HCl [pH 7.6], 137 mM NaCl, 0.5% [vol/vol] Tween 20) containing 5% (wt/vol) nonfat dry milk. The membrane was then incubated overnight with the primary antibody. After washing with TBST buffer, the membrane was incubated with the secondary antibody for 30 minutes. Proteins were visualized using the ECL detection reagent from Amersham (Little Chalfont, United Kingdom). RT-PCR.
Total RNA was prepared from cultured AFT024 cells using Trizol (Life
Technologies, Rockville, MD.) following the manufacturer's instructions. RNA was converted to cDNA using oligo-dT primer and
Superscript II reverse transcriptase (Invitrogen, San Diego, CA). For
polymerase chain reactions (PCRs), 100 ng of the cDNA pool was
amplified. PCR cycles were optimized for each set of primers. Primer
sequences were as follows: MEF2C (myocyte-enhancer factor 2C),
forward (fwd): 5'-CCATTGGACTCACCAGACCT-3', reverse (rev):
5'-AGCACACACACACACTGCAA-3'; HNF3 Cobblestone area-forming cell (CAFC) assays Depletion of lineage-positive cells.
Six to 10 C57BL/6 female 4- to 8-week-old mice were killed. Bone marrow
cells were repeatedly flushed from femurs and tibias using PBS with
10% FCS. Aggregates were dissociated by passing cells through 23-gauge
needles. The single-cell suspension (total of 108 cells per
mL) was then incubated for 20 minutes at 4°C with a mixture of
monoclonal rat antibodies (Becton Dickinson) directed against membrane
antigens specific for red cells (Ter119), B lymphocytes (B220, clone
RA3-6B2), T lymphocytes (CD4, clone GK1.5; and CD8, clone 53-6.5),
granulocytes (Gr-1, clone RB6-8C5), and myelomonocytic cells (Mac-1,
clone M1/70). Cells were then incubated with magnetic beads coated with
goat antirat IgG (Miltenyi, Cologne, Germany) for 15 minutes at 4°C
and passaged through a magnetic column to enrich for lineage-negative
cells (lin Progenitor cell assays.
A total of 500 to 1000 lin CAFCs. Stromal cells from the different lines were subcultured in 96-well plates precoated with 0.1% (wt/vol) gelatin and grown to confluence. Confluent plates were irradiated at 20 Gy and maintained at 37°C. Sorted lin cells were seeded at limiting dilution on the
pre-established irradiated adherent layers treated or not with OSM (10 ng/mL) in the long-term culture medium. Dilutions ranged from 2000 to 1 lin cells per well. Eight to 32 replicate wells were
tested for each cell dilution. Cultures were incubated for 5 weeks at
37°C, 5% CO2 with weekly half-medium change. Wells with
hematopoietic colonies were scored every week. CAFC frequency was
estimated by plotting the proportion of negative wells versus the
number of cells per well. Poisson distribution of the clonogenic cells
was checked (linear regression, no intercept with the y- or x-axis),
and the frequency measured using the value obtained for 37% negative wells.
Transmission electron microscopy studies Livers collected from embryos and fetuses were fixed at 4°C in 2.5% (vol/vol) glutaraldehyde in PBS for 90 minutes, washed twice in PBS, postfixed in 2% (wt/vol) osmium tetroxide, dehydrated in graded ethanol, and embedded in epoxy resin. Thin sections (76 nm) were cut and examined with a JEOL 100C electron microscope after uranyl acetate and lead citrate staining.Immunofluorescence studies of mouse liver biopsies Livers collected from embryo, fetus, and adult mice as indicated above were fixed in 4% (vol/vol) paraformaldehyde in PBS for 12 hours at 4°C, rinsed in PBS, and then twice in 15% (wt/vol) sucrose in 0.12 M phosphate buffer for at least 24 hours. The tissue was then embedded in 15% (wt/vol) sucrose, 7.5% (wt/vol) gelatin in 0.12 M phosphate buffer and frozen in isopentane at the temperature of liquid nitrogen and then stored at 20°C. Five-micron-thick frozen
sections were thawed, hydrated in PBS, and treated with acetone at
20°C for 15 minutes. Sections were sequentially incubated for 1 hour each at room temperature with monoclonal rat Ter119 or mouse
35 H11 and then with goat antirat or goat antimouse antibodies coupled to Alexa 488. The 1A4 monoclonal mouse antibody directly coupled to cyanin-3 (Cy3) was then added. For negative controls, the
primary antibodies were omitted or replaced by unrelated
isotype-matched immunoglobulins. Slides were mounted in Mowiol
(Calbiochem, La Jolla, CA) and examined and photographed under a DMR HC
fluorescence microscope (Leica, Vienna, Austria) using a planapo oil
immersion objective (25 × or 63 ×).
Statistical analysis Results are given as mean ± standard error (m ± sem). Comparisons between means were made using the Student t test and Mann-Whitney nonparametric U test.
Stroma from hematopoietic fetal liver consists of a cell population with both epithelial and mesenchymal features To characterize the phenotype of cells making up the fetal liver microenvironment, we generated long-term cultures of liver cells from 14-gw human and 14.5-dpc murine fetuses. The adherent cell layer was examined after 5 to 10 days in culture. As shown in Figure 1, double immunofluorescence using the anti-ASMA 1A4 monoclonal antibody coupled to Cy-3 and the 35H11 anti-cytokeratin-8 (anti-CK-8)
monoclonal antibody labeled with Alexa 488 revealed a population that
coexpressed the mesenchymal marker ASMA and the epithelial marker CK-8.
ASMA was localized in microfilaments forming stress fibers in human
cells (Figure 1A) or a cortical network in murine cells (Figure 1B),
while CK-8 formed perinuclear intermediate filaments in both human and
murine cells (Figure 1A-B). We confirmed this phenotype on the clonal
stromal cell lines derived from 14-dpc murine fetal liver, AFT024 and
2018. Most cells from these lines coexpress ASMA and CK-8 (Figure
1C-D). ASMA was present in stress fibers and in filopodia in AFT024
cells (Figure 1C) and in stress fibers and a cortical network in 2018 cells (Figure 1D), while CK-8 was detected in perinuclear intermediate filaments in cells from both lines (Figure 1C-D). This phenotype is
reminiscent of an epithelial-to-mesenchymal transition (EMT) as
described by others using vimentin33 or desmin and
ASMA34 as mesenchymal markers and cytokeratins as
epithelial marker.
To further characterize this EMT, permeabilized AFT024 cells and 2018 cells (not shown) were analyzed by flow cytometry (Figure 2A), Western blotting (Figure 2B), and
reverse transcriptase (RT)-PCR (Figure 2C). AFT024 cells not
only expressed CK-8 and ASMA but also expressed the following
mesenchymal markers previously used for stromal cell
characterization36,37: vimentin, osteopontin, and collagen
I (osteogenic differentiation), calponin, thrombospondin-1, and the
fibronectin isoform comprising the alternatively spliced EDa domain
(EDa FN) (vascular smooth muscle differentiation). We also found that
AFT024 cells expressed the myogenic transcription factor
MEF2C38 that plays a role for smooth muscle
recruitment in early development and the membrane antigen Stro-1, which
is found positive in vascular smooth muscle cells and
pericytes.39 The following epithelial markers were also
expressed:
These data indicate that stromal cells with both epithelial
(CK-8+, AFP+, E-cadherin+,
albumin+, and HNF3 The population of EMT cells is no longer detected in late gestation fetal liver Hematopoiesis in fetal liver is known to peak by 12.5 to 14.5 dpc in the mouse and by 12 to 20 gw in humans and to decrease by the end of gestation. We looked for this decline in hematopoietic capacity by assessing clonogenic progenitors on nonadherent cells from the long-term cultures. Liver cells were cultured for 10 days in the long-term culture medium and then collected and plated for colony-forming units (CFUs) that were enumerated after 10 days in methylcellulose (Figure 3A). Between 14.5 and 18 dpc, there was a highly significant (P < .02) decrease in granulocyte macrophage CFUs (CFU-GMs) (4-fold), erythroid burst-forming units (BFU-Es) (3-fold), and granulocyte, erythroid, macrophage, megakaryocyte CFUs (CFU-GEMMs) (12.5-fold). Similarly, cultures from human fetal liver revealed a decrease in CFU-GMs (5-fold), BFU-Es (12-fold), and CFU-GEMMs (10-fold) between 14 and 28 gw.
Phenotypic analyses on adherent cells were performed in parallel to clonogenic assays (Figure 3B). By 18 dpc the population expressing both mesenchymal and epithelial markers was no longer detected. Instead, 2 populations were apparent. One population, comprising approximately 70% of the adherent cells, was made of large cells expressing CK-8 in a conspicuous intermediate filament network. The other population consisted of cells expressing ASMA in conspicuous stress fibers. A similar pattern was observed for liver cells from a 28-gw human fetus. These data indicate that, at late gestation time when hematopoiesis has severely declined, EMT cells, characteristic of the hematopoietic florid phase, are replaced by a majority of epithelial cells resembling mature hepatocytes and a minority of mesenchymal cells similar to hepatic Ito cells/myofibroblasts. Oncostatin M directly affects the stromal cell phenotype, down-regulating EMT and up-regulating hepatocytic differentiation The data above suggest that hematopoiesis in fetal liver is associated with a specific stromal cell population with EMT features. One way to confirm this association was to induce in culture the maturation of fetal hepatocytes and examine whether intrinsic hematopoiesis was consequently affected. Previous studies have established that oncostatin M (OSM) is one factor responsible for this maturation.16,40,41 We added 10 ng/mL recombinant mouse OSM to long-term fetal liver cultures established from 14.5-dpc murine fetus. Morphologic analyses were performed on cultures grown for 10 days with or without OSM. Results are shown in Figure 4. In culture without OSM, most of the cells had EMT features: oval, nonrefringent, and expressing CK-8 (but not CK-19), AFP, and ASMA. These cells were surrounded by hematopoietic cells: smaller, round, refringent, and expressing CD45. In OSM-supplemented cultures, hematopoietic cells were no longer apparent. The adherent layer was made of tightly packed polygonal cells with prominent nuclei. Most of these cells showed extended intermediate filaments, containing either CK-8 or CK-19, and expressed low cytoplasmic levels of AFP (and high levels of albumin; not shown). A distinct subpopulation is made of cells with conspicuous ASMA+ stress fibers but lacking expression of CK-8, CK-19, and AFP (also albumin-negative, not shown). These data indicate that the addition of OSM results in the disappearance of hematopoietic cells and the replacement of the EMT population by hepatocytes and myofibroblasts. Addition of OSM mimics, therefore, what is observed during fetal liver development, from the hematopoietic florid period until the end of gestation.
We additionally checked the effect of OSM on the clonal fetal liver
line AFT024. Immunoblots, using AFT024 cells treated with or without 10 ng/mL OSM and extracted after 10 days, are shown in Figure
5A. Amounts of proteins per lane are
similar, as shown by similar band intensity for
Flow cytometry analysis was also performed on clonal lines 2018 and BFC012 (Figure 5C). Compared with AFT024, these lines expressed higher basal levels of CK-8, lower levels of ASMA, and levels of AFP just above background. OSM-induced modifications of the markers were more clear-cut in 2018 cells (decrease in ASMA, increase in albumin and in CK-8) than in BFC012 cells (decrease in ASMA, increase in albumin, but not significant in CK-8). These data indicate that OSM has a direct effect on fetal stromal
cells, because its addition induced a shift in the phenotype of stromal
cells, from EMT cells (ASMA+, CK-8+, and
AFP++) to hepatocytes (ASMA OSM-induced modifications in the stromal cell phenotype are associated to a decrease in the hematopoietic supportive ability To investigate whether OSM-induced hepatocytic differentiation would affect the hematopoiesis supportive ability of fetal liver stroma, we studied the generation of cobblestone area-forming cells (CAFCs) from lineage-negative marrow precursors cocultured for 5 weeks with the 3 fetal liver cell lines (AFT024, 2018, and BFC012) in the presence or absence of OSM. To make sure that the effect of OSM was specific for fetal liver stroma, a bone marrow stromal cell line (MS-5) was subjected to the same CAFC assay. We confirmed that this cell line did not express epithelial markers and did not undergo morphologic change after treatment with OSM (not shown).We first verified that OSM had no direct effect on the
lin Limiting dilutions for CAFCs generated after 5 weeks from
lin
These data indicate that, in fetal liver stromal cells, phenotypic modifications are associated with modifications in the hematopoietic supportive ability. Decline in CAFC maintenance appears to correlate with hepatocytic maturation, either from EMT hepatoblasts treated with OSM (in AFT024 and, to a lesser extent, in 2018 cells) or in the absence of OSM treatment (in BFC012 cells). The in vivo fetal liver microenvironment contains cells similar to EMT hepatoblasts To assess whether cells in EMT are found in fetal liver during the florid hematopoietic phase, we looked for cells expressing both ASMA and CK-8 in biopsies from embryonic, fetal, and adult murine liver. Results are shown in Figure 7A. Most nonhematopoietic cells at 11.5 dpc expressed both ASMA and CK-8. At 12.5 and 14.5 dpc such cells constituted a large subpopulation that tended, at 14.5 dpc, to locate in the vicinity of central veins (although being clearly distinct from pericytes that are more elongated and express only ASMA). At 18.5 dpc and in the adult, the population expressing both ASMA and CK-8 was no longer detectable. Instead, hepatocytes constituting the lobules were CK-8+, while ASMA+ smooth muscle cells and pericytes were observed in the wall of central veins and of portal veins and arteries.
Biopsies were also stained using anti-ASMA and TER119 (recognizing erythroblasts) antibodies. Results are shown in Figure 7B. In all instances, labeling with TER119 was clearly distinct from that of ASMA. Some erythroblasts are observed at 11.5 dpc. At 12.5 and 14.5 dpc, erythroblasts were very numerous in hepatic lobules and some, circulating, are visible in the central veins. By 18.5 dpc, this population has largely regressed and, in adult liver, erythroblasts were no longer apparent. The CFU content of embryonic and fetal livers (Figure 7C) was correlated to the number of erythroblasts detected in liver biopsies. There was a maximum at 12.5 to 14.5 dpc and a sharp decline at 18.5 dpc. All these data were confirmed by a quantitative analysis (Table
1) showing the distribution of each
cell type throughout the development (11.5 dpc to adulthood): cells
expressing CK-8 only (epithelial cells), cells expressing ASMA only
(vascular smooth muscle cells and pericytes), cells expressing both
markers (EMT cells), and cells expressing Ter119 (erythroid cells).
Each percentage represents the number of cells in each category related to the total number of cells. At early stages of development (11.5 dpc)
when hematopoietic cells are believed to migrate into the liver and
expand, EMT cells were the major nonhematopoietic cell population,
comprising 60% (± 3%) of all cells. A dramatic decrease was
observed after 11.5 dpc, because at 12.5 dpc the EMT cells were only
18% and at 14.5 dpc 5% (P < .01); moreover, at this time point, these cells were confined to the perivascular spaces. In
neonatal and adult stage, this population disappeared while erythroid
cells were rare and most parenchymal cells had differentiated along the
hepatocytic lineage.
Ultrastructural studies confirmed the intimate relationship between
hematopoietic and epithelial cells and showed the maturation along the
hepatocytic pathway by the end of gestation. Results are shown in
Figure 8. At day 11.5 dpc, few
hematopoietic cells not yet clearly differentiated into erythroid
lineage were observed among epithelial cells characterized by a clear
nucleus with well-delineated nucleoli and the presence in the cytoplasm
of numerous large mitochondria and extended rough endoplasmic
reticulum. At 12.5 dpc the number of hematopoietic cells with clear-cut
erythrocytic features had increased. Remarkably, at 14.5 dpc, bile
canaliculi are observed among maturing hepatocytes (one of these
contains a large lipid vacuole). At 18.5 dpc, the liver had acquired
its definitive adult architecture. Sinusoids were obvious, limited by
endothelial cells flanked on their abluminal site by stellate Ito
cells. Cells with true hepatocytic features (cytoplasmic glycogen
deposits and low nucleus-to-cytoplasm ratio) were numerous.
Altogether, these data indicate that EMT stromal cells were observed in the fetal liver microenvironment following a time course parallel to that of hematopoiesis. Such a pattern suggests that this phenotype is related to the development of fetal liver hematopoiesis.
Our study suggests that stromal cells (ie, cells with
hematopoietic supportive ability) from the fetal liver are cells with epithelial-to-mesenchymal (EMT) features because (1) stromal cells grown (primary cultures or lines) from fetal liver in the hematopoietic florid phase express both mesenchymal (vimentin, osteopontin, collagen
I, Different cell populations that may be responsible for the transient hematopoiesis observed in fetal liver have been described. Epithelial cells (developing hepatocytes) were first considered because of their spatial relationship to hematopoietic cells.42 An epithelial line with hematopoietic support generated from 15-dpc mouse fetal liver.43 Also, c-jun44 and XBP-145 knock-out mice exhibited impairment of both hematopoietic and hepatic lineages. Although the embryonic lethality was due to defective hematopoiesis, HSCs present in these mice were able to reconstitute the entire hematopoietic system in lethally irradiated mice, and embryonic stem cells lacking these genes contributed to all tissues except hepatocytes. Finally, fetal liver epithelial cells were shown to express the CD166 hematopoietic cell adhesion (HCA) molecule operative in the interaction between HSCs and stromal cells.46 Other studies have suggested that fetal liver cells of mesodermal origin were responsible for hematopoietic support: endothelial cells and perivascular cells47 and fibroblasts.48 Recently, it has been shown that mice null for the jumonji gene, expressed by both endothelial cells and fibroblasts, showed defect in fetal liver hematopoiesis not due to HSC impairment.49 In earlier studies, we have suggested that vascular smooth muscle-like mesenchymal cells/myofibroblasts would be the fetal liver microenvironmental cell population.35,36 Myofibroblasts derived from perisinusoidal stellate cells/Ito cells are commonly found in the liver.50,51 This population apparented to pericytes52 is particularly abundant in rat fetal liver where it is associated to hematopoietic foci.34 Our present study reveals a more complex phenotype because stromal cells express both epithelial and mesenchymal markers, corresponding to EMT cells. EMT appears, therefore, to be another characteristic of the developing hepatic epithelial cell, adding to the numerous distinctive features of this immature cell set. EMT occurs frequently during development, at different times and in distinct organs,31,32 including the liver.33,34 We confirmed the role of OSM on the hepatocytic maturation, as already
underlined by the group of Miyajima.16,40,41 In particular, OSM induced a strong decline in AFP expression and the
appearance of hepatocytic cords while increasing the expression of CK-8
and albumin. OSM may act in concert with glucocorticoids (contained in
the culture medium), other cytokines such as transforming growth
factor- We also confirmed that hepatocytic maturation of fetal liver stroma parallels the decline in hematopoietic supporting ability. OSM decreased, by 4-fold, week 5 CAFCs generated in the presence of AFT024 cells while inducing a clear-cut shift from an EMT to a hepatocytic phenotype in cells from this line. The OSM-induced decrease in week 5 CAFCs was only 2-fold in the presence of 2018 cells where the phenotypic shift was less marked. Finally, week 5 CAFCs were not maintained in the presence of BFC012 cells displaying a more mature hepatocytic phenotype. Results obtained in cultured cells were confirmed by in vivo observations because EMT cells were present during the hematopoietic phase of liver development (11.5 until 14.5 dpc included). Ultrastructure studies confirmed the close association between epithelial and hematopoietic cells. The existence of cells in rat fetal livers expressing both mesenchymal markers (desmin) and epithelial marker (CK-8) has been suggested but not demonstrated by Kiassov et al.34 In our work, we have not detected desmin-positive cells, perhaps because liver cells from mouse and human origin differ in their expression profile from the rat. Previous data have demonstrated that OSM is expressed by CD45+ hematopoietic cells in the mouse liver starting from 12 dpc to the neonatal stage and that its receptor, OSM-R, is expressed by hepatic cells starting from 14.5 dpc to adult stage.56 Taken together, our data and that of others would fit with a model explaining the transient hematopoiesis in the fetal liver: hematopoietic cells from yolk sac and AGM would migrate into the liver rudiment where they would find the suitable microenvironment of EMT cells. Following expansion and differentiation of hematopoietic cells, by 14 dpc in the mouse, levels of OSM would be enough to induce the hepatocytic maturation of EMT cells; consequently, the liver would lose its ability to support hematopoiesis. EMT cells were already observed in 11.5-dpc murine liver, which suggests that endodermal (stem?) cells express mesenchymal markers early after specification of the hepatic lineages. Alternatively, liver mesenchymal stem cells57 may acquire endodermal features and then give rise to hepatocytes, following the controversial hypothesis of a mesodermal origin of the liver parenchyma.30 The generation of EMT cells is also compatible with other hypothetical founder cells, a mesendodermal cell (a precursor common to endodermal and mesodermal cells),11,58 or a circulating HSC seeding the liver rudiment.23,24 Another possibility is that fetal liver contains multipotent progenitor cells similar to those recently identified in adult bone marrow (multipotent adult progenitor cells [MAPCs]). These cells are able to generate mesoderm, endoderm, and neuroectoderm cells.59 An interesting hypothesis would be that such cells exist in fetal liver, where they could generate both mesenchymal and epithelial components of the fetal liver microenvironment. Moreover, these cells that may seed the bone marrow together with HSCs by the end of gestation would be resident embryonic stem cells persisting in the adult bone marrow.
We are grateful to Dr Kateri Moore (Department of Molecular Biology, Princeton University, NJ) for kindly providing the 3 fetal liver lines used in this study. We are indebted to Dr K. Moore and Dr B. Péault for their comments and critical revision of the manuscript. We would like to acknowledge F. Noel for his assistance and advice with Western blot experiments and D. Gilges for her assistance with RT-PCR experiments.
Submitted May 7, 2002; accepted December 4, 2002.
Prepublished online as Blood First Edition Paper, December 27, 2002; DOI 10.1182/blood-2002-05-1341.
Supported by research grants from the Association pour la Recherche sur le Cancer (ARC no. 5837) and the Association pour la Recherche sur les Myopathies/Institut National de la Santé et de la Recherche Médicale (AFM/INSERM no. 4CS02F). J.C. was supported by a grant from the Groupe d'Etude Hemostase et Thrombose and the Ligue Nationale contre le Cancer.
The publication costs of this article were defrayed in part by page charge payment. Therefore, and solely to indicate this fact, this article is hereby marked "advertisement" in accordance with 18 U.S.C. section 1734.
Reprints: Jalila Chagraoui, Bâtiment Lavoisier, Hôpital Paul Brousse, 12, Av P Vaillant-Couturier, 94807, Villejuif, France; e-mail: jali{at}netcourrier.com.
1. Dzierzak E, Sanchez MJ, Muller A, et al. Hematopoietic stem cells: embryonic beginnings. J Cell Physiol. 1997;173:216-218[CrossRef][Medline] [Order article via Infotrieve].
2.
Morrison SJ, Hemmati HD, Wandycz AM, Weissman IL.
The purification and characterization of fetal liver hematopoietic stem cells.
Proc Natl Acad Sci U S A.
1995;92:10302-10306 3. Jordan CT, McKearn JP, Lemischka IR. Cellular and developmental properties of fetal hematopoietic stem cells. Cell. 1990;61:953-963[CrossRef][Medline] [Order article via Infotrieve].
4.
Traver D, Miyamoto T, Christensen J, Iwasaki-Arai J, Akashi K, Weissman IL.
Fetal liver myelopoiesis occurs through distinct, prospectively isolatable progenitor subsets.
Blood.
2001;98:627-635
5.
Nicolini FE, Holyoake TL, Cashman JD, Chu PP, Lambie K, Eaves CJ.
Unique differentiation programs of human fetal liver stem cells shown both in vitro and in vivo in NOD/SCID mice.
Blood.
1999;94:2686-2695
6.
Emerson SG, Thomas S, Ferrara JL, Greenstein JL.
Developmental regulation of erythropoiesis by hematopoietic growth factors: analysis on populations of BFU-E from bone marrow, peripheral blood, and fetal liver.
Blood.
1989;74:49-55
7.
Lansdorp PM, Dragowska W, Mayani H.
Ontogeny-related changes in proliferative potential of human hematopoietic cells.
J Exp Med.
1993;178:787-791
8.
Gualdi R, Bossard P, Zheng M, Hamada Y, Coleman JR, Zaret KS.
Hepatic specification of the gut endoderm in vitro: cell signaling and transcriptional control.
Genes Dev.
1996;10:1670-1682 9. Le Douarin NM. An experimental analysis of liver development. Med Biol. 1975;53:427-455[Medline] [Order article via Infotrieve]. 10. Fukuda-Taira S. Location of pre-hepatic cells in the early developmental stages of quail embryos. J Embryol Exp Morphol. 1981;64:73-85[Medline] [Order article via Infotrieve]. 11. Zaret KS. Hepatocyte differentiation: from the endoderm and beyond. Curr Opin Genet Dev. 2001;11:568-574[CrossRef][Medline] [Order article via Infotrieve]. 12. Hamazaki T, Iiboshi Y, Oka M, et al. Hepatic maturation in differentiating embryonic stem cells in vitro. FEBS Lett. 2001;497:15-19[CrossRef][Medline] [Order article via Infotrieve].
13.
Shiojiri N, Lemire JM, Fausto N.
Cell lineages and oval cell progenitors in rat liver development.
Cancer Res.
1991;51:2611-2620 14. Fukumoto T. Possible developmental interactions of hematopoietic cells and hepatocytes in fetal rat liver. Biomed Res. 1992;13:385-413.
15.
Malhotra K, Luehrsen KR, Costello LL, et al.
Identification of differentially expressed mRNAs in human fetal liver across gestation.
Nucleic Acids Res.
1999;27:839-847 16. Kamiya A, Kinoshita T, Ito Y, et al. Fetal liver development requires a paracrine action of oncostatin M through the gp130 signal transducer. EMBO J. 1999;18:2127-2136[CrossRef][Medline] [Order article via Infotrieve]. 17. Thorgeirsson SS. Hepatic stem cells in liver regeneration. FASEB J. 1996;10:1249-1256[Abstract]. 18. Petersen BE, Goff JP, Greenberger JS, Michalopoulos GK. Hepatic oval cells express the hematopoietic stem cell marker Thy-1 in the rat. Hepatology. 1998;27:433-445[CrossRef][Medline] [Order article via Infotrieve]. 19. Baumann U, Crosby HA, Ramani P, Kelly DA, Strain AJ. Expression of the stem cell factor receptor c-kit in normal and diseased pediatric liver: identification of a human hepatic progenitor cell? Hepatology. 1999;30:112-117[CrossRef][Medline] [Order article via Infotrieve]. 20. Deutsch G, Jung J, Zheng M, Lora J, Zaret KS. A bipotential precursor population for pancreas and liver within the embryonic endoderm. Development. 2001;128:871-881[Abstract].
21.
Yang L, Li S, Hatch H, et al.
In vitro trans-differentiation of adult hepatic stem cells into pancreatic endocrine hormone-producing cells.
Proc Natl Acad Sci U S A.
2002;99:8078-8083
22.
Suzuki A, Zheng YW, Kaneko S, et al.
Clonal identification and characterization of self-renewing pluripotent stem cells in the developing liver.
J Cell Biol.
2002;156:173-184 23. Lagasse E, Connors H, Al-Dhalimy M, et al. Purified hematopoietic stem cells can differentiate into hepatocytes in vivo. Nat Med. 2000;6:1229-1234[CrossRef][Medline] [Order article via Infotrieve].
24.
Korbling M, Katz RL, Khanna A, et al.
Hepatocytes and epithelial cells of donor origin in recipients of peripheral-blood stem cells.
N Engl J Med.
2002;346:738-746 25. Overturf K, al-Dhalimy M, Ou CN, Finegold M, Grompe M. Serial transplantation reveals the stem-cell-like regenerative potential of adult mouse hepatocytes. Am J Pathol. 1997;151:1273-1280[Abstract].
26.
Dabeva MD, Hwang SG, Vasa SR, et al.
Differentiation of pancreatic epithelial progenitor cells into hepatocytes following transplantation into rat liver.
Proc Natl Acad Sci U S A.
1997;94:7356-7361
27.
Petersen BE, Bowen WC, Patrene KD, et al.
Bone marrow as a potential source of hepatic oval cells.
Science.
1999;284:1168-1170 28. Theise ND, Badve S, Saxena R, et al. Derivation of hepatocytes from bone marrow cells in mice after radiation-induced myeloablation. Hepatology. 2000;31:235-240[CrossRef][Medline] [Order article via Infotrieve]. 29. Alison MR, Poulsom R, Jeffery R, et al. Hepatocytes from non-hepatic adult stem cells. Nature. 2000;406:257[CrossRef][Medline] [Order article via Infotrieve]. 30. Sell S. Heterogeneity and plasticity of hepatocyte lineage cells. Hepatology. 2001;33:738-750[CrossRef][Medline] [Order article via Infotrieve]. 31. Viebahn C. Epithelio-mesenchymal transformation during formation of the mesoderm in the mammalian embryo. Acta Anat. 1995;154:79-97[Medline] [Order article via Infotrieve]. 32. Davies JA. Mesenchyme to epithelium transition during development of the mammalian kidney tubule. Acta Anat. 1996;156:187-201[Medline] [Order article via Infotrieve]. 33. Pagan R, Llobera M, Vilaro S. Epithelial-mesenchymal transition in cultured neonatal hepatocytes. Hepatology. 1995;21:820-831[CrossRef][Medline] [Order article via Infotrieve]. 34. Kiassov AP, Van Eyken P, van Pelt JF, et al. Desmin expressing nonhematopoietic liver cells during rat liver development: an immunohistochemical and morphometric study. Differentiation. 1995;59:253-258[CrossRef][Medline] [Order article via Infotrieve].
35.
Moore KA, Ema H, Lemischka IR.
In vitro maintenance of highly purified, transplantable hematopoietic stem cells.
Blood.
1997;89:4337-4347 36. Remy-Martin JP, Marandin A, Challier B, et al. Vascular smooth muscle differentiation of murine stroma: a sequential model. Exp Hematol. 1999;27:1782-1795[CrossRef][Medline] [Order article via Infotrieve]. 37. Charbord P, Oostendorp R, Pang W, et al. A comparative study of stromal cell lines derived from embryonic, fetal and post-natal mouse blood-forming tissues. Exp Hematol. 2002;30:1-9[Medline] [Order article via Infotrieve]. 38. Lin Q, Lu J, Yanagisawa H, et al. Requirement of the MADS-box transcription factor MEF2C for vascular development. Development. 1998;125:4565-4574[Abstract].
39.
Bianco P, Riminucci M, Gronthos S, Robey PG.
Bone marrow stromal stem cells: nature, biology, and potential applications.
Stem Cells.
2001;19:180-192
40.
Kinoshita T, Sekiguchi T, Xu MJ, et al.
Hepatic differentiation induced by oncostatin M attenuates fetal liver hematopoiesis.
Proc Natl Acad Sci U S A.
1999;96:7265-7270 41. Kinoshita T, Nagata K, Sorimachi N, Karasuyama H, Sekiguchi T, Miyajima A. Oncostatin M suppresses generation of lymphoid progenitors in fetal liver by inhibiting the hepatic microenvironment. Exp Hematol. 2001;29:1091-1097[CrossRef][Medline] [Order article via Infotrieve]. 42. Medlock ES, Haar JL. The liver hemopoietic environment: I. Developing hepatocytes and their role in fetal hemopoiesis. Anat Rec. 1983;207:31-41[CrossRef][Medline] [Order article via Infotrieve]. 43. Hata M, Nanno M, Doi H, et al. Establishment of a hepatocytic epithelial cell line from the murine fetal liver capable of promoting hemopoietic cell proliferation. J Cell Physiol. 1993;154:381-392[CrossRef][Medline] [Order article via Infotrieve]. 44. Hilberg F, Aguzzi A, Howells N, Wagner EF. c-jun is essential for normal mouse development and hepatogenesis. Nature. 1993;365:179-181[CrossRef][Medline] [Order article via Infotrieve].
45.
Reimold AM, Etkin A, Clauss I, et al.
An essential role in liver development for transcription factor XBP-1.
Genes Dev.
2000;14:152-157
46.
Cortes F, Deschaseaux F, Uchida N, et al.
HCA, an immunoglobulin-like adhesion molecule present on the earliest human hematopoietic precursor cells, is also expressed by stromal cells in blood-forming tissues.
Blood.
1999;93:826-837 47. Bankston PW, Pino RM. The development of the sinusoids of fetal rat liver: morphology of endothelial cells, Kupffer cells, and the transmural migration of blood cells into the sinusoids. Am J Anat. 1980;159:1-15[CrossRef][Medline] [Order article via Infotrieve]. 48. Tsai S, Emerson SG, Sieff CA, Nathan DG. Isolation of a human stromal cell strain secreting hemopoietic growth factors. J Cell Physiol. 1986;127:137-145[CrossRef][Medline] [Order article via Infotrieve].
49.
Kitajima K, Kojima M, Nakajima K, et al.
Definitive but not primitive hematopoiesis is impaired in jumonji mutant mice.
Blood.
1999;93:87-95 50. Yokoi Y, Namihisa T, Kuroda H, et al. Immunocytochemical detection of desmin in fat-storing cells (Ito cells). Hepatology. 1984;4:709-714[Medline] [Order article via Infotrieve]. 51. Bachem MG, Meyer D, Melchior R, Sell KM, Gressner AM. Activation of rat liver perisinusoidal lipocytes by transforming growth factors derived from myofibroblastlike cells. A potential mechanism of self perpetuation in liver fibrogenesis. J Clin Invest. 1992;89:19-27[Medline] [Order article via Infotrieve]. 52. Pinzani M, Failli P, Ruocco C, et al. Fat-storing cells as liver-specific pericytes. Spatial dynamics of agonist-stimulated intracellular calcium transients. J Clin Invest. 1992;90:642-646[Medline] [Order article via Infotrieve].
53.
Sanchez A, Pagan R, Alvarez AM, et al.
Transforming growth factor- 54. Sanchez A, Alvarez AM, Pagan R, et al. Fibronectin regulates morphology, cell organization and gene expression of rat fetal hepatocytes in primary culture. J Hepatol. 2000;32:242-250[CrossRef][Medline] [Order article via Infotrieve]. 55. Pagan R, Sanchez A, Martin I, Llobera M, Fabregat I, Vilaro S. Effects of growth and differentiation factors on the epithelial-mesenchymal transition in cultured neonatal rat hepatocytes. J Hepatol. 1999;31:895-904[CrossRef][Medline] [Order article via Infotrieve]. 56. Miyajima A, Kinoshita T, Tanaka M, Kamiya A, Mukouyama Y, Hara T. Role of Oncostatin M in hematopoiesis and liver development. Cytokine Growth Factor Rev. 2000;11:177-183[CrossRef][Medline] [Order article via Infotrieve].
57.
Campagnoli C, Roberts IA, Kumar S, Bennett PR, Bellantuono I, Fisk NM.
Identification of mesenchymal stem/progenitor cells in human first-trimester fetal blood, liver, and bone marrow.
Blood.
2001;98:2396-2402 58. Rodaway A, Patient R. Mesendoderm: an ancient germ layer? Cell. 2001;105:169-172[CrossRef][Medline] [Order article via Infotrieve]. 59. Jiang Y, Jahagirdar BN, Reinhardt RL, et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature. 2002;418:41-44[CrossRef][Medline] [Order article via Infotrieve].
© 2003 by The American Society of Hematology.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
 |
|
 |
|
  T. Kisseleva and D. A. Brenner Mechanisms of Fibrogenesis Experimental Biology and Medicine, February 1, 2008; 233(2): 109 - 122. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Sato, K. Harada, S. Ozaki, S. Furubo, K. Kizawa, T. Sanzen, M. Yasoshima, H. Ikeda, M. Sasaki, and Y. Nakanuma Cholangiocytes with Mesenchymal Features Contribute to Progressive Hepatic Fibrosis of the Polycystic Kidney Rat Am. J. Pathol., December 1, 2007; 171(6): 1859 - 1871. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. G. Phinney and D. J. Prockop Concise Review: Mesenchymal Stem/Multipotent Stromal Cells: The State of Transdifferentiation and Modes of Tissue Repair Current Views Stem Cells, November 1, 2007; 25(11): 2896 - 2902. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Zeisberg, C. Yang, M. Martino, M. B. Duncan, F. Rieder, H. Tanjore, and R. Kalluri Fibroblasts Derive from Hepatocytes in Liver Fibrosis via Epithelial to Mesenchymal Transition J. Biol. Chem., August 10, 2007; 282(32): 23337 - 23347. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Kaimori, J. Potter, J.-y. Kaimori, C. Wang, E. Mezey, and A. Koteish Transforming Growth Factor-beta1 Induces an Epithelial-to-Mesenchymal Transition State in Mouse Hepatocytes in Vitro J. Biol. Chem., July 27, 2007; 282(30): 22089 - 22101. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. L. Ponte, E. Marais, N. Gallay, A. Langonne, B. Delorme, O. Herault, P. Charbord, and J. Domenech The In Vitro Migration Capacity of Human Bone Marrow Mesenchymal Stem Cells: Comparison of Chemokine and Growth Factor Chemotactic Activities Stem Cells, July 1, 2007; 25(7): 1737 - 1745. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Kinoshita, Y. Iimuro, K. Otogawa, S. Saika, Y. Inagaki, Y. Nakajima, N. Kawada, J. Fujimoto, S. L Friedman, and K. Ikeda Adenovirus-mediated expression of BMP-7 suppresses the development of liver fibrosis in rats Gut, May 1, 2007; 56(5): 706 - 714. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Chateauvieux, J.-L. Ichante, B. Delorme, V. Frouin, G. Pietu, A. Langonne, N. Gallay, L. Sensebe, M. T. Martin, K. A. Moore, et al. Molecular profile of mouse stromal mesenchymal stem cells Physiol Genomics, April 24, 2007; 29(2): 128 - 138. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. K. Sicklick, S. S. Choi, M. Bustamante, S. J. McCall, E. H. Perez, J. Huang, Y.-X. Li, M. Rojkind, and A. M. Diehl Evidence for epithelial-mesenchymal transitions in adult liver cells Am J Physiol Gastrointest Liver Physiol, October 1, 2006; 291(4): G575 - G583. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Y. Dan, K. J. Riehle, C. Lazaro, N. Teoh, J. Haque, J. S. Campbell, and N. Fausto Isolation of multipotent progenitor cells from human fetal liver capable of differentiating into liver and mesenchymal lineages PNAS, June 27, 2006; 103(26): 9912 - 9917. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. P.S. Monga, M. S. Hout, M. J. Baun, A. Micsenyi, P. Muller, L. Tummalapalli, A. R. Ranade, J.-H. Luo, S. C. Strom, and J. C. Gerlach Mouse Fetal Liver Cells in Artificial Capillary Beds in Three-Dimensional Four-Compartment Bioreactors Am. J. Pathol., November 1, 2005; 167(5): 1279 - 1292. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. C.D. van IJzendoorn, D. Theard, J. M. van der Wouden, W. Visser, K. A. Wojtal, and D. Hoekstra Oncostatin M-stimulated Apical Plasma Membrane Biogenesis Requires p27Kip1-Regulated Cell Cycle Dynamics Mol. Biol. Cell, September 1, 2004; 15(9): 4105 - 4114. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Lanza, M. A.S. Moore, T. Wakayama, A. C.F. Perry, J.-H. Shieh, J. Hendrikx, A. Leri, S. Chimenti, A. Monsen, D. Nurzynska, et al. Regeneration of the Infarcted Heart With Stem Cells Derived by Nuclear Transplantation Circ. Res., April 2, 2004; 94(6): 820 - 827. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Yan, T. Devos, L. Yu, G. Xia, O. Rutgeerts, J. Goebels, C. Segers, Y. Lin, M. Vandeputte, and M. Waer Pathogenesis of Autoimmunity After Xenogeneic Thymus Transplantation J. Immunol., June 15, 2003; 170(12): 5936 - 5946. [Abstract] [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
 |
 |
 |
|||||||
 |
 |
 |
 |
 |
 |
 |
 |
||
| Copyright © 2003 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||
Top
Abstract
Introduction
smooth muscle actin,
thrombospondin-1, EDa fibronectin, calponin, Stro-1 antigens,
myocyte-enhancer factor 2C) and epithelial (
) or not (
). CAFC frequencies
(determined at 37% negative wells) were measured at week 5. Data shown
are the means of 4 experiments.
